Abstract

P1.02-007 TP53 and DNA-Repair Gene Polymorphisms as Risk Factors for the Development of Advanced Lung Adenocarcinoma in Serbia

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Abstract 4821: Association of polymorphisms in TP53, CXCL2, MDM2, MDM4 and BCL2 genes and proliferative prostate diseases among Lebanese men
Ruhul H Kuddus ... Asmahan A El Ezzi
American Journal of Cancer | VOL. 75
Ruhul H Kuddus, et. al.Ruhul H Kuddus ... Asmahan A El Ezzi
01 Aug 2015
Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut
Min Shen ... Nathaniel Rothman
Human Genetics | VOL. 119
Min Shen, et. al.Min Shen ... Nathaniel Rothman
26 Apr 2006
The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK
Sherif Z Abdel-Rahman ... Randa A El-Zein
Cancer Letters | VOL. 159
Sherif Z Abdel-Rahman, et. al.Sherif Z Abdel-Rahman ... Randa A El-Zein
06 Sep 2000
Polymorphisms in DNA repair genes and breast cancer risk in Russian population: a case-control study.
Alexandra S Shadrina ... Valentina D Petrova
Clinical and Experimental Medicine | VOL. 16
Alexandra S Shadrina, et. al.Alexandra S Shadrina ... Valentina D Petrova
24 Dec 2014
View more papers

More From: Journal of Thoracic Oncology

Paper Title
Journal
Date
Author
Analysis of Circulating Tumor DNA Predicts Outcomes of Short-Course Consolidation Immunotherapy in Unresectable Stage III NSCLC
Soyeong Jun ... Maximilian Diehn
Journal of Thoracic Oncology | VOL. -
Soyeong Jun, et. al.Soyeong Jun ... Maximilian Diehn
05 Jul 2024
PP01.133 Clinical and Economic Outcomes Associated with Genomic Testing Strategies in Real-World Data in Advanced Non-Small Cell Lung Cancer (aNSCLC)
Benjamin Levy ... Teddy Saliba
Journal of Thoracic Oncology | VOL. 19
Benjamin Levy, et. al.Benjamin Levy ... Teddy Saliba
01 Jul 2024
PP01.99 Switching to Subcutaneous (SC) Atezolizumab After Intravenous (IV) Dosing: Evaluation of Atezolizumab Pharmacokinetics (PK) Using Population PK Modeling
Stephanie N Liu ... Benjamin Wu
Journal of Thoracic Oncology | VOL. 19
Stephanie N Liu, et. al.Stephanie N Liu ... Benjamin Wu
01 Jul 2024
PP01.11 Real-world treatment patterns and outcomes among unresectable Stage III Non-Small Cell Lung Cancer
Ashwini Arunachalam ... Jerome Goldschmidt
Journal of Thoracic Oncology | VOL. 19
Ashwini Arunachalam, et. al.Ashwini Arunachalam ... Jerome Goldschmidt
01 Jul 2024
View more papers